Prot# EXC 001-202: A Phase 2, Randomized, Double-Blind, Within-Subject Controlled Study to Evaluate Efficacy and Safety of EXC 001 for the Amelioration of Scarring of the Surgical Incision in Subjects Undergoing an Elective Abdominoplasty

Project: Research project

Project Details

StatusFinished
Effective start/end date12/16/09 → 12/15/12

Funding

  • Excaliard Pharmaceuticals, Inc. (Prot# EXC 001-202)